A detailed history of Balyasny Asset Management LLC transactions in Conmed Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 95,450 shares of CNMD stock, worth $6.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,450
Previous 172,016 44.51%
Holding current value
$6.9 Million
Previous $11.9 Million 42.44%
% of portfolio
0.01%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.09 - $76.92 $4.91 Million - $5.89 Million
-76,566 Reduced 44.51%
95,450 $6.86 Million
Q2 2024

Aug 14, 2024

SELL
$61.9 - $80.36 $7.97 Million - $10.4 Million
-128,831 Reduced 42.82%
172,016 $11.9 Million
Q1 2024

May 13, 2024

BUY
$75.36 - $112.51 $19.7 Million - $29.4 Million
261,126 Added 657.4%
300,847 $24.1 Million
Q4 2023

Feb 14, 2024

SELL
$91.3 - $115.05 $3.8 Million - $4.78 Million
-41,578 Reduced 51.14%
39,721 $4.35 Million
Q3 2023

Nov 14, 2023

BUY
$97.55 - $135.91 $7.93 Million - $11 Million
81,299 New
81,299 $8.2 Million
Q1 2023

May 15, 2023

SELL
$89.75 - $107.27 $1.92 Million - $2.29 Million
-21,370 Reduced 36.55%
37,099 $3.85 Million
Q4 2022

Feb 14, 2023

BUY
$72.84 - $94.04 $4.26 Million - $5.5 Million
58,469 New
58,469 $5.18 Million
Q2 2022

Aug 15, 2022

BUY
$88.23 - $154.18 $825,744 - $1.44 Million
9,359 Added 4.52%
216,495 $20.7 Million
Q1 2022

May 16, 2022

BUY
$121.88 - $150.0 $25.2 Million - $31.1 Million
207,136 New
207,136 $30.8 Million
Q4 2021

Feb 14, 2022

SELL
$129.86 - $157.03 $14.4 Million - $17.4 Million
-110,571 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$122.87 - $139.12 $13.6 Million - $15.4 Million
110,571 New
110,571 $14.5 Million
Q2 2021

Aug 16, 2021

SELL
$128.08 - $145.09 $15.8 Million - $17.9 Million
-123,231 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$111.35 - $130.59 $13.7 Million - $16.1 Million
123,231 New
123,231 $16.1 Million
Q4 2020

Feb 16, 2021

SELL
$77.7 - $112.82 $10.7 Million - $15.6 Million
-138,097 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$69.87 - $89.2 $4.56 Million - $5.83 Million
-65,306 Reduced 32.11%
138,097 $10.9 Million
Q2 2020

Aug 14, 2020

BUY
$50.31 - $81.76 $10.2 Million - $16.6 Million
203,403 New
203,403 $14.6 Million
Q3 2019

Nov 14, 2019

SELL
$83.97 - $102.19 $4.8 Million - $5.84 Million
-57,182 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$78.27 - $86.94 $3.56 Million - $3.95 Million
45,464 Added 387.98%
57,182 $4.89 Million
Q1 2019

May 15, 2019

BUY
$60.79 - $83.18 $353,433 - $483,608
5,814 Added 98.48%
11,718 $975,000
Q4 2018

Feb 14, 2019

BUY
$57.41 - $79.06 $116,886 - $160,966
2,036 Added 52.64%
5,904 $379,000
Q3 2018

Nov 14, 2018

SELL
$73.09 - $81.64 $533,264 - $595,645
-7,296 Reduced 65.35%
3,868 $306,000
Q2 2018

Aug 14, 2018

SELL
$61.34 - $76.43 $128,016 - $159,509
-2,087 Reduced 15.75%
11,164 $817,000
Q1 2018

May 15, 2018

BUY
$50.61 - $64.53 $670,633 - $855,087
13,251 New
13,251 $839,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.2B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.